These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 22374248)
1. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India. Srivastava P; Lone TA; Kapoor R; Mittal RD Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248 [TBL] [Abstract][Full Text] [Related]
2. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer]. Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692 [TBL] [Abstract][Full Text] [Related]
3. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. O-Charoenrat P; Khantapura P Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157 [TBL] [Abstract][Full Text] [Related]
4. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886 [TBL] [Abstract][Full Text] [Related]
5. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564 [TBL] [Abstract][Full Text] [Related]
6. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort. Srivastava P; Kapoor R; Mittal RD Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201 [TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India. Srivastava P; Kapoor R; Mittal RD Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671 [TBL] [Abstract][Full Text] [Related]
8. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians. Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195 [TBL] [Abstract][Full Text] [Related]
9. The role of MMP2 (-1306C>T) and TIMP2 (-418 G>C) promoter variants in age-related macular degeneration. Ortak H; Demir S; Ateş Ö; Benli İ; Söğüt E; Sahin M Ophthalmic Genet; 2013 Dec; 34(4):217-22. PubMed ID: 23536957 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma. Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421 [TBL] [Abstract][Full Text] [Related]
11. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study. Banday MZ; Sameer AS Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064 [No Abstract] [Full Text] [Related]
12. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort. Mandal RK; Mittal RD Arch Med Res; 2011 Oct; 42(7):620-6. PubMed ID: 22023987 [TBL] [Abstract][Full Text] [Related]
13. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis]. Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216 [TBL] [Abstract][Full Text] [Related]
15. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease. Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860 [TBL] [Abstract][Full Text] [Related]
16. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163 [TBL] [Abstract][Full Text] [Related]
17. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer. Sharma KL; Misra S; Kumar A; Mittal B Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753 [TBL] [Abstract][Full Text] [Related]
18. Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis. Aksoy D; Ateş Ö; Kurt S; Çevik B; Sümbül O J Investig Med; 2016 Aug; 64(6):1143-7. PubMed ID: 27174941 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106 [TBL] [Abstract][Full Text] [Related]
20. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Miao X; Yu C; Tan W; Xiong P; Liang G; Lu W; Lin D Cancer Res; 2003 Jul; 63(14):3987-90. PubMed ID: 12873995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]